News Industry News Extended Follow-Up Of ANTHEM-HF Patients Shows That Benefits Of Autonomic Regulation Therapy Are Maintained After 12 Months September 28, 2015
News Industry News Resverlogix Officially Attains Phase 3 Status with a European Regulatory Authority June 22, 2015
News Industry News Shimadzu receives FDA clearance for three digital angiography systems March 26, 2014